ENOV · NYSE · STOCK
Enovis (ENOV) Stock Analysis
$19.20
52W $16.70 – $34.28
61/100
$1.09B
-1.0
1.43
Is ENOV Bullish or Bearish?
Bullish.
Innellis AI committee rates Enovis Corporation (ENOV) Buy with a composite score of 61/100
, based on 5 analysts with 60% agreement.
Last updated October 14, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.77 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.23 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- Price-to-book of 1.0x is a discount to asset value — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- ROE of only -68.2% -- cheap may mean cheap for a reason — Value
- Price structure making lower highs and lower lows — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 14, 2026
Overall Committee Score
61/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 25%
of 192 Healthcare peers
Value Analyst
neutral
55
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 1.0x is a discount to asset value
− ROE of only -68.2% -- cheap may mean cheap for a reason
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
56
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
35
/ 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score weakened from 64.3 to 61.2.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Macro Analyst: score 80->65 (-15).
- Portfolio Manager: score 30->35 (+5).
- Technical Analyst: +1 bearish signal(s).
Comparing 2026-10-13 to 2026-10-14 (1 day apart).
Technical Analysis
RSI (14)
54.0
Neutral
MACD Histogram
0.303
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Bollinger %B
0.76
Inside Bands
Price vs Moving Averages
EMA 9
$18.29
Above
EMA 21
$18.67
Above
EMA 50
$20.47
Below
EMA 200
$24.05
Below
Fundamental Analysis
Valuation
100
Growth
86
Profitability
23
Financial Health
89
Cash Flow
70
Valuation
P/E Ratio
-1.0×
P/B Ratio
0.74×
PEG Ratio
0.02
Dividend Yield
0.00%
52W High
$34.28
52W Low
$16.70
Quality & Growth
ROE
-7951.2%
ROA
-3088.7%
Gross Margin
5743.2%
Operating Margin
413.6%
Revenue Growth YoY
—
Debt / Equity
0.93
AI Fundamental Assessment
P/E ratio of -1.0 (inexpensive relative to a 15-40x range); Price-to-book of 0.7x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -79.5%; Return on assets of -30.9%; Net margin of -48.0%; Gross margin of 57.4%; Current ratio of 1.98 (healthy short-term liquidity); Debt-to-equity of 0.93; Free cash flow per share is positive (1.11); Most recent quarter beat estimates by 4.0%; 4 consecutive earnings beats; EPS growth accelerating (-6.3% -> +1.1% QoQ); Analyst estimates rising over recent quarters
Get the Full ENOV Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →